Superior Hypogastric Plexus Blockade in Laparoscopic Hysterectomy
Efficacy of Intraoperative Superior Hypogastric Plexus Blockade for Postoperative Pain in Laparoscopic Hysterectomy
1 other identifier
observational
60
1 country
1
Brief Summary
The primary indication for superior hypogastric plexus (SHP) block is visceral pelvic pain, most commonly from malignancy of the ovary, uterus, cervix, bladder, rectum or prostate. Per-cutaneous SHP blocks should be done under guidance of ultrasonography, fluoroscopy, magnetic resonance or computed tomography. During minimally invasive laparoscopic surgery, percutaneous technique can be done under the guidance of cameras.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2018
CompletedFirst Posted
Study publicly available on registry
February 9, 2018
CompletedStudy Start
First participant enrolled
March 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedMarch 20, 2018
March 1, 2018
3 months
February 1, 2018
March 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
postoperative pain scores (PACU)
Patients' pain scores will be scored with a 10 cm Visual Analogue Scale (VAS). Each will be scored between 0-10 (0: no pain; 10: worst pain ever)
1 hour (postoperatively)
postoperative opioid/NSAID consumption (PACU)
nonsteroid antiinflammatory drugs (NSAID) or opioid drugs that are applied to patients will be noted down.
1 hour (postoperatively)
rescue analgesic time
Time to first analgesic demand at gynecology ward (after transfer from PACU to gynecology ward)
48 hours (first analgesic demand time will be noted down)
postoperative pain scores (ward)
Patients' pain scores will be scored with a 10 cm Visual Analogue Scale (VAS). Each will be scored between 0-10 (0: no pain; 10: worst pain ever)
48 hours (postoperatively)
postoperative opioid/NSAID consumption (ward)
NSAID or opioid drugs that are applied to patients will be noted down. Target VAS score for NSAID is \>4; if there is no response to NSAID and pain is worsening opioid drugs will be applied
48 hours (total)
Secondary Outcomes (3)
Intraoperative hemodynamics
from SHP block to the end of the surgery (approximately 15 min)
length of stay
3-5 days (expected)
complications due to SHP block
3-5 days (from surgery to discharge from the hospital)
Study Arms (2)
Hypo
The participants with a superior hypogastric block
NoHypo
The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retroperitone is opened intraoperatively by the surgeon)
Interventions
superior hypogastric blockade during surgery
Eligibility Criteria
The patients who are scheduled for elective laparoscopic hysterectomy under general anesthesia.
You may qualify if:
- ASA I - II
- Elective laparoscopic hysterectomy
You may not qualify if:
- ASA III
- Different kind of surgery
- Known allergy to local anesthetic drugs
- Different analgesia protocol (ie: epidural, TAP block,..)
- Refusal of the patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Derince Training and Research Hospital
Kocaeli, Derince, 41900, Turkey (Türkiye)
Related Publications (5)
Song T, Kim MK, Jung YW, Yun BS, Seong SJ, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG. Minimally invasive compared with open surgery in patients with borderline ovarian tumors. Gynecol Oncol. 2017 Jun;145(3):508-512. doi: 10.1016/j.ygyno.2017.03.019. Epub 2017 Apr 2.
PMID: 28381342RESULTLovich-Sapola J, Smith CE, Brandt CP. Postoperative pain control. Surg Clin North Am. 2015 Apr;95(2):301-18. doi: 10.1016/j.suc.2014.10.002. Epub 2015 Jan 24.
PMID: 25814108RESULTSindt JE, Brogan SE. Interventional Treatments of Cancer Pain. Anesthesiol Clin. 2016 Jun;34(2):317-39. doi: 10.1016/j.anclin.2016.01.004.
PMID: 27208713RESULTErdine S, Yucel A, Celik M, Talu GK. Transdiscal approach for hypogastric plexus block. Reg Anesth Pain Med. 2003 Jul-Aug;28(4):304-8. doi: 10.1016/s1098-7339(03)00191-3.
PMID: 12945023RESULTAytuluk HG, Kale A, Basol G. Laparoscopic Superior Hypogastric Blocks for Postoperative Pain Management in Hysterectomies: A New Technique for Superior Hypogastric Blocks. J Minim Invasive Gynecol. 2019 May-Jun;26(4):740-747. doi: 10.1016/j.jmig.2018.08.008. Epub 2018 Aug 28.
PMID: 30165185DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hande Aytuluk, MD
Derince Training and Research Hospital
- STUDY CHAIR
Ahmet Kale, Prof
Derince Training and Research Hospital
- STUDY CHAIR
Gulfem Basol, MD
Derince Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Principal investigator
Study Record Dates
First Submitted
February 1, 2018
First Posted
February 9, 2018
Study Start
March 18, 2018
Primary Completion
June 30, 2018
Study Completion
July 1, 2018
Last Updated
March 20, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share
The investigators do not prefer to share the study plan and records.